跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,048 条关于
“Galderma S.A.”
全部
2,048
临床试验
1,036
药物
317
机构
512
资讯
183
上个月
Global Botulinum Toxin Market Poised to Reach $29 Billion by 2035, Driven by Aesthetic Democratization and Expanding Therapeutic Indications
去年
Oncodesign Precision Medicine Presents Positive Phase 1 Data for RIPK2 Inhibitor OPM-101 in Healthy Volunteers
2个月前
FDA Issues Complete Response Letter to Galderma for RelabotulinumtoxinA Over Manufacturing Observations
4个月前
Galderma Launches Alastin Regenerative Skincare Brand Across Japan and Asia-Pacific Markets
2个月前
Galderma Lifts Full-Year Guidance as H1 2026 Sales Surge 24.6% to $3.13 Billion
去年
Galderma Showcases Latest Aesthetic Portfolio Data at IMCAS 2025, Highlighting Relfydess and Restylane Advances
8个月前
Galderma Presents Phase 3 Data on Relfydess Neuromodulator at TOXINS 2026, Demonstrating Superior Efficacy and Duration
9个月前
Galderma Initiates Phase II Trial of Nemolizumab for Chronic Pruritus of Unknown Origin
2年前
Nemolizumab Shows Long-Term Efficacy in Atopic Dermatitis and Prurigo Nodularis
去年
Galderma Reports Nine-Month Efficacy Data for Combined Sculptra and Restylane Treatment in GLP-1-Associated Facial Volume Loss
第 1 页,共 19 页
上一页
下一页